158 related articles for article (PubMed ID: 25478316)
1. Structure-based evolution of subtype-selective neurotensin receptor ligands.
Schaab C; Kling RC; Einsiedel J; Hübner H; Clark T; Seebach D; Gmeiner P
ChemistryOpen; 2014 Oct; 3(5):206-18. PubMed ID: 25478316
[TBL] [Abstract][Full Text] [Related]
2. Impact of the proline residue on ligand binding of neurotensin receptor 2 (NTS2)-selective peptide-peptoid hybrids.
Held C; Hübner H; Kling R; Nagel YA; Wennemers H; Gmeiner P
ChemMedChem; 2013 May; 8(5):772-8. PubMed ID: 23532897
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia.
Eiselt E; Gonzalez S; Martin C; Chartier M; Betti C; Longpré JM; Cavelier F; Tourwé D; Gendron L; Ballet S; Sarret P
ACS Chem Neurosci; 2019 Nov; 10(11):4535-4544. PubMed ID: 31589400
[TBL] [Abstract][Full Text] [Related]
4. Opening the amino acid toolbox for peptide-based NTS2-selective ligands as promising lead compounds for pain management.
Previti S; Desgagné M; Tourwé D; Cavelier F; Sarret P; Ballet S
J Pept Sci; 2023 Jun; 29(6):e3471. PubMed ID: 36539999
[TBL] [Abstract][Full Text] [Related]
5. Use of Molecular Modeling to Design Selective NTS2 Neurotensin Analogues.
Fanelli R; Floquet N; Besserer-Offroy É; Delort B; Vivancos M; Longpré JM; Renault P; Martinez J; Sarret P; Cavelier F
J Med Chem; 2017 Apr; 60(8):3303-3313. PubMed ID: 28368584
[TBL] [Abstract][Full Text] [Related]
6. Development of a metabolically stable neurotensin receptor 2 (NTS2) ligand.
Held C; Plomer M; Hübner H; Meltretter J; Pischetsrieder M; Gmeiner P
ChemMedChem; 2013 Jan; 8(1):75-81. PubMed ID: 23097347
[TBL] [Abstract][Full Text] [Related]
7. NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.
Smith KE; Boules M; Williams K; Richelson E
Behav Brain Res; 2012 Jun; 232(1):93-7. PubMed ID: 22504145
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic and pharmacokinetic profiles of a neurotensin receptor type 2 (NTS2) analgesic macrocyclic analog.
Chartier M; Desgagné M; Sousbie M; Rumsby C; Chevillard L; Théroux L; Haroune L; Côté J; Longpré JM; Boudreault PL; Marsault É; Sarret P
Biomed Pharmacother; 2021 Sep; 141():111861. PubMed ID: 34229249
[TBL] [Abstract][Full Text] [Related]
9. Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations.
Kling RC; Burchardt C; Einsiedel J; Hübner H; Gmeiner P
J Mol Model; 2019 Jun; 25(7):193. PubMed ID: 31209646
[TBL] [Abstract][Full Text] [Related]
10. NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids.
Simeth NA; Bause M; Dobmeier M; Kling RC; Lachmann D; Hübner H; Einsiedel J; Gmeiner P; König B
Bioorg Med Chem; 2017 Jan; 25(1):350-359. PubMed ID: 27842797
[TBL] [Abstract][Full Text] [Related]
11. Effect of amphetamine on extracellular concentrations of amino acids in striatum in neurotensin subtype 1 and 2 receptor null mice: a possible interaction between neurotensin receptors and amino acid systems for study of schizophrenia.
Li Z; Liang Y; Boules M; Gordillo A; Richelson E
Neuropharmacology; 2010 Jun; 58(7):1174-8. PubMed ID: 20193696
[TBL] [Abstract][Full Text] [Related]
12. Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimetics.
Einsiedel J; Held C; Hervet M; Plomer M; Tschammer N; Hübner H; Gmeiner P
J Med Chem; 2011 Apr; 54(8):2915-23. PubMed ID: 21446649
[TBL] [Abstract][Full Text] [Related]
13. Optimized Opioid-Neurotensin Multitarget Peptides: From Design to Structure-Activity Relationship Studies.
Gonzalez S; Dumitrascuta M; Eiselt E; Louis S; Kunze L; Blasiol A; Vivancos M; Previti S; Dewolf E; Martin C; Tourwé D; Cavelier F; Gendron L; Sarret P; Spetea M; Ballet S
J Med Chem; 2020 Nov; 63(21):12929-12941. PubMed ID: 32902268
[TBL] [Abstract][Full Text] [Related]
14. Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals.
Belmeguenai A; Vaudry H; Leprince J; Vivet B; Cavelier F; Martinez J; Louiset E
Neuroendocrinology; 2000 Dec; 72(6):379-91. PubMed ID: 11146421
[TBL] [Abstract][Full Text] [Related]
15. Potent spinal analgesia elicited through stimulation of NTS2 neurotensin receptors.
Sarret P; Esdaile MJ; Perron A; Martinez J; Stroh T; Beaudet A
J Neurosci; 2005 Sep; 25(36):8188-96. PubMed ID: 16148226
[TBL] [Abstract][Full Text] [Related]
16. Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic.
Chartier M; Desgagné M; Sousbie M; Côté J; Longpré JM; Marsault E; Sarret P
J Med Chem; 2021 Feb; 64(4):2110-2124. PubMed ID: 33538583
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin(8-13) analogs as dual NTS1 and NTS2 receptor ligands with enhanced effects on a mouse model of Parkinson's disease.
Kühl T; Georgieva MG; Hübner H; Lazarova M; Vogel M; Haas B; Peeva MI; Balacheva AA; Bogdanov IP; Milella L; Ponticelli M; Garev T; Faraone I; Detcheva R; Minchev B; Petkova-Kirova P; Tancheva L; Kalfin R; Atanasov AG; Antonov L; Pajpanova TI; Kirilov K; Gastreich M; Gmeiner P; Imhof D; Tzvetkov NT
Eur J Med Chem; 2023 Jun; 254():115386. PubMed ID: 37094450
[TBL] [Abstract][Full Text] [Related]
18. Improved radiosynthesis and preliminary in vivo evaluation of a (18)F-labeled glycopeptide-peptoid hybrid for PET imaging of neurotensin receptor 2.
Maschauer S; Greff C; Einsiedel J; Ott J; Tripal P; Hübner H; Gmeiner P; Prante O
Bioorg Med Chem; 2015 Jul; 23(14):4026-33. PubMed ID: 25691211
[TBL] [Abstract][Full Text] [Related]
19. Radical arylation of tyrosine and its application in the synthesis of a highly selective neurotensin receptor 2 ligand.
Pratsch G; Unfried JF; Einsiedel J; Plomer M; Hübner H; Gmeiner P; Heinrich MR
Org Biomol Chem; 2011 May; 9(10):3746-52. PubMed ID: 21472182
[TBL] [Abstract][Full Text] [Related]
20. Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice.
Liang Y; Boules M; Li Z; Williams K; Miura T; Oliveros A; Richelson E
Neuropharmacology; 2010 Jun; 58(8):1199-205. PubMed ID: 20211191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
